Colon Cancer

Higher cardiorespiratory fitness linked to lower risk of death from colon, lung, prostate cancers

FOLFOXIRI plus bevacizumab "preferred" for certain tumors

Most intermediate-risk cases can be cured without pelvic radiation, says investigator

New rule came in response to concerns over proposed prior authorization policy

Also in TTHealthWatch: promoting "goals of care" discussions

Two-year mortality decreased for three types of GI cancer in expansion vs non-expansion states

Payer policy will impact those with "highest risk of abnormalities"

The policy adds delays to care and may worsen health outcomes

ctDNA-identified wild-type tumors benefited most from adding panitumumab to standard therapy

Quality of life similar to those getting usual care

Clearly helpful in manufacturers' trials, but not so much in routine practice

Outdone by gastroenterologists in finding adenomatous polyps

But not a cure-all in states boosting eligibility

No increase in adverse events or toxicity versus surgery alone